Rein Therapeutics Inc.
RNTX
$0.92
-$0.03-2.98%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.84M | -31.97M | -5.58M | -6.82M | -5.50M |
| Total Depreciation and Amortization | -- | 0.00 | 0.00 | 1.00K | -- |
| Total Amortization of Deferred Charges | 623.00K | -- | -- | -- | -- |
| Total Other Non-Cash Items | 156.00K | 29.01M | 1.85M | 256.00K | 264.00K |
| Change in Net Operating Assets | 1.64M | -260.00K | 186.00K | 147.00K | -938.00K |
| Cash from Operations | -3.42M | -3.22M | -3.55M | -6.42M | -6.18M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 4.30M | -1.90M | 1.90M | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 354.00K | 1.46M | 0.00 | 1.25M | 738.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 2.85M | 0.00 | 3.47M | -- |
| Cash from Financing | 4.65M | 2.41M | 1.90M | 4.71M | 738.00K |
| Foreign Exchange rate Adjustments | -- | -18.00K | -26.00K | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.23M | -833.00K | -1.67M | -1.71M | -5.44M |